E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/27/2011 in the Prospect News PIPE Daily.

Derma Sciences pockets $29.07 million via private placement of stock

Company sells common shares, five-year warrants in brokered offering

By Devika Patel

Knoxville, Tenn., June 27 - Derma Sciences, Inc. said it raised $29.07 million through a private placement of stock. The deal priced for about $29 million on June 20. Jennison Associates LLC, RA Capital Management and Deerfield Management were the lead investors.

The company sold 3,524,239 common shares at $8.25 per share. The price per share is a 1.32% discount to the June 17 closing share price of $8.36.

Investors also received warrants for 1,762,118 shares. The warrants are each exercisable at $9.90 for five years. The strike price is an 18.42% premium to the June 17 closing price of $8.36.

The offering was conducted by lead agents Oppenheimer & Co. Inc. and Canaccord Genuity Inc. Roth Capital Partners and Rodman & Renshaw were advisors.

Proceeds will be used to advance the company's pharmaceutical product DSC127 into phase 3 trials for the treatment of diabetic foot ulcers, to hire additional salespeople for the company's advanced wound care products, to repay debt and for general corporate purposes.

Princeton, N.J.-based Derma Sciences manufactures and markets advanced wound care products.

Issuer:Derma Sciences, Inc.
Issue:Common stock
Amount:$29,074,972
Shares:3,524,239
Price:$8.25
Warrants:For 1,762,118 shares
Warrant expiration:Five years
Warrant strike price:$9.90
Agents:Oppenheimer & Co. Inc. and Canaccord Genuity Inc. (leads)
Investors:Jennison Associates LLC, RA Capital Management and Deerfield Management
Pricing date:June 20
Settlement date:June 27
Stock symbol:Nasdaq: DSCI
Stock price:$8.36 at close June 17
Market capitalization:$56.38 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.